1、White PaperUnlocking Pharmaceutical Potential:The Growing Role of Thai Clinics AKRIM JANTARAPRAPA,Principal,Strategy ConsultingNATTAPOL KONTIKAME,ConsultantTable of contentsIntroduction 1Clinics 101:Characteristics of current clinic landscape 3Conclusion 7References 8Authors 9About IQVIA 9 |1Since t

2、he end of the COVID lockdown,the pharmaceutical market in Thailand has seen rapid growth within the clinics channel:both prescription(Rx)and over-the-counter drug sales are expanding at a faster rate compared to public hospitals,private hospitals,and pharmacies.For the top 15 multinational corporati

3、on(MNC)pharmaceuticals,sales across clinics have grown at a faster rate(25%compound annual growth rate CAGR)than those at private hospitals,public hospitals,and pharmacies.In 2024,sales at clinics for the top 15 MNCs exceeded USD 100 million,equivalent to 40%of sales at private hospitals during the

4、same period a significant rise from 33%in 2022.Consumers ongoing need for greater convenience and their increasing willingness to pay out of pocket for health and wellbeing are two factors propelling the clinics rapid expansion.Despite Thailand being a predominantly public reimbursement market,the i

5、nconvenience of long queues at medical schools and public hospitals has driven patients to seek quicker,more accessible alternatives for minor ailments.With adoption of teleconsultation still in its infancy,clinics located in residential areas or close to places of employment have emerged as the go-

6、to choice for patients who cannot wait more than an hour at public hospitals.Up to 80%of patients at clinics wait less than half an hour.Consumers ongoing need for greater convenience and their increasing willingness to pay out of pocket for health and wellbeing are two factors propelling the clinic